tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
PremiumRatingsAdicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
1M ago
Adicet Bio price target raised to $8 from $7 at Guggenheim
Premium
The Fly
Adicet Bio price target raised to $8 from $7 at Guggenheim
1M ago
Adicet Bio Receives Nasdaq Extension for Compliance
Premium
Company Announcements
Adicet Bio Receives Nasdaq Extension for Compliance
1M ago
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
PremiumRatingsAdicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
1M ago
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
Premium
Ratings
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
3M ago
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
Premium
Ratings
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
3M ago
Adicet Bio Announces 30% Workforce Reduction Strategy
PremiumCompany AnnouncementsAdicet Bio Announces 30% Workforce Reduction Strategy
4M ago
Adicet Bio assumed with a Buy at H.C. Wainwright
Premium
The Fly
Adicet Bio assumed with a Buy at H.C. Wainwright
4M ago
Adicet Bio Elects Directors and Approves Key Proposals
Premium
Company Announcements
Adicet Bio Elects Directors and Approves Key Proposals
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100